Related Experiment Video
Updated: Aug 5, 2026
11:36
Glycan Node Analysis: A Bottom-up Approach to Glycomics
Published on: May 22, 2016
Increased glycodelin levels in gynecological malignancies
1Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Summary
This study found higher levels of the immunosuppressive protein glycodelin in patients with gynecological cancers. Elevated glycodelin may contribute to tumor growth in these malignancies.
Area of Science:
- Reproductive immunology
- Gynecologic oncology
- Protein biochemistry
Background:
- Glycodelin is an immunosuppressive protein with known contraceptive properties.
- Its synthesis by reproductive tissues is significant in pregnancy and disease.
- Understanding glycodelin's role in gynecological conditions is crucial.
Purpose of the Study:
- To investigate plasma glycodelin levels in patients with malignant gynecological tumors.
- To compare glycodelin expression in tumor tissues versus controls.
- To explore the potential link between glycodelin and gynecological cancer progression.
Main Methods:
- Development of a polyclonal antibody against a synthetic glycodelin peptide sequence.
- Utilized an enzyme-linked immunosorbent assay (ELISA) to quantify plasma glycodelin levels.
- Measured glycodelin levels in subjects with endometrial, ovarian, and cervical cancers compared to controls.
Main Results:
- A significant elevation in plasma glycodelin levels was observed in patients with endometrial, ovarian, and cervical cancers compared to healthy controls.
- Endometrial and ovarian tumor tissues exhibited strong expression of both glycodelin mRNA and protein.
- The developed ELISA assay demonstrated sensitivity in detecting glycodelin down to 5 ng/ml.
Conclusions:
- Increased plasma glycodelin levels are associated with gynecological malignancies.
- Elevated glycodelin expression in tumor tissues suggests a role in local disease.
- Glycodelin's immunosuppressive properties may promote the growth of gynecological tumors.
More Related Videos
Related Concept Videos
01:05Proteoglycans
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...